期刊文献+

血管内皮及其分泌因子在血压调节中作用机制 被引量:15

Vascular Endothelial and Secreted Factor in Mechanism of Blood Pressure Regulation
下载PDF
导出
摘要 高血压是危害人类健康的主要疾病,可导致心脑肾及其他血管系统的病变。目前我国有2.5亿高血压患者,成人患病率为25%-30%,高血压的防治及研究需要不断深入。血管内皮在调节血流和血压方面发挥着重要作用,高血压患者存在血管内皮功能损伤,而内皮功能异常加速高血压进程及其靶器官损害,同时促进动脉粥样硬化的发生发展。该文对血管内皮及其分泌的因子在血压调节中的作用机制进行概述。 Hypertension is a major disease harmful to human health and can lead to cardiovascular and renal diseases and other vascular system diseases. At present,our country has 250 million hypertensive patients and the adult prevalence rate is 25%-30%. Its prevention and treatment needs further study. The vascular endothelium plays an important role in regulation of blood flow and blood pressure and the endothelial dysfunction exists in hypertensive patients and endothelial dysfunction accelerates the progress of hypertension and target organ damage and promotes the development of atherosclerosis. This paper outlined the mechanisms of vascular endothelium and its secretory factors in blood pressure regulation.
出处 《辽宁中医药大学学报》 CAS 2015年第3期60-64,共5页 Journal of Liaoning University of Traditional Chinese Medicine
基金 国家重点基础研究发展计划(973计划)项目(2012CB518505)
关键词 血管内皮因子 血压调节 作用机制 vascular endothelial growth factor regulation of blood pressure mechanism of action
  • 相关文献

参考文献51

  • 1Alexander RW,Dzau VJ.Vascular biology:the past 50 years[J].Circulation,2000,102:IV112-IV116.
  • 2Dharmashankar K,Widlansky ME.Vascular endothelial function and hypertension:insights and directions[J].Current Hypertension Reports,2010,12(6):448-455.
  • 3Touyz RM,Burger D,Biomarkers in hypertension[J].Special issues in hypertension,2012(1):237-246.
  • 4陈明,胡申江.高血压病血管内皮功能障碍及治疗[J].心血管病学进展,2005,26(3):222-226. 被引量:31
  • 5Allen BG,Walsh MP.The biochemical basis of the regulation of mooth-muscle contraction.Trends Biochem Scien[J].Sci,1994,19(9):362-368.
  • 6Hendriks MC,Peters SLM,Michel MC,et al.Regulation of G protein-coupled receptor signalling:Focus on the cardiovascular system and regulator of G protein signalling proteins[J].European Jour of Pharmacology,2008,585(2-3):278-291.
  • 7Bader M,Ganten D.Update on tissure rennin-angiotensin systems[J].J Mol Med,2008,86(6):615-621.
  • 8Machado RDP,Santos RAS,Andrade SP.Mechanisms ofangiotension-(1-7)- induced inhibition of angiogenesis[J].Am J Physiol Regul Integr Comp Physiol,2001,280:R994-R1000.
  • 9Michael Bader.Tissue Renin-Angiotensin-Aldosterone Systems:targets for pharmacological therapy[J].Annu Rev Pharmacol Toxicol,2010,50:439-465.
  • 10Sharma JN,Sherif GJ.Pharmacologic targets and prototype therapeutics in the Kallikrein-Kinin System:bradykinin receptor agonists or antagonists[J].Scientific World Jour,2006,6:1247-1261.

二级参考文献50

  • 1杨建梅,童裕庆,姜维洁,王佑华,周端.高血压病血栓前状态与中医证型相关性研究[J].上海中医药杂志,2009,43(2):20-22. 被引量:2
  • 2郭永红,罗金燕.TGF-β超家族与Smad信号转导研究进展[J].医学综述,2005,11(8):685-688. 被引量:24
  • 3管冬元,方肇勤.中医证候与基因相关性研究的现状与反思[J].中医杂志,2005,46(8):569-571. 被引量:8
  • 4董昌武,高尔鑫.从易感基因多态性探讨原发性高血压病中医证候实质的思考[J].中医杂志,2006,47(12):883-885. 被引量:9
  • 5中国高血压防治指南修订委员会.中国高血压防治指南2005年修订版[S].2005.
  • 6Zhang XM, Miao XP, Tan W, et al. Identification of functional genet- ic variants in cyclooxygenase-2 and their association with risk of e- sophageal cancer[ J ]. Gastroenmrology ,2005 ,129 (2) :565-576.
  • 7Sano H, Kawahito Y, Wilder RI, et al. Expression of cyclooxygenase- 1 and-2 in human colorectal cancer [ J]. Cancer Res, 1995,55 ( 17 ) :3785-3789.
  • 8Applehy SB, Ristimki A, Neilson K, et al. Structure of the human cyclooxygenase-2 gene [ J ]. Biochem J, 1994,302 ( Pt 3 ) :723-727.
  • 9Howe LR, Subbaramaiah K, Brown AM, et al. Cyclooxygenase-2 : A target for the prevention and treatment of breast cancer [ J ]. En- docr Relat Cancer, 2001,8(2) :97-99.
  • 10Telliez A, Furman C, Pommery N, et al. Mechanisms leading to COX- 2 expression and COX-2 induced tumorigenesis:topical therapeutic strategies targeting COX-2 expression and activity [J]. Anticancer A- gents Med Chem,2006,6 ( 3 ) : 187-208.

共引文献42

同被引文献217

引证文献15

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部